- Home
- DDL vs RLAY Comparison
DDL vs RLAY Comparison
Compare DDL & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDL
- RLAY
- Stock Information
- Founded
- DDL 2014
- RLAY 2015
- Country
- DDL China
- RLAY United States
- Employees
- DDL N/A
- RLAY N/A
- Industry
- DDL Catalog/Specialty Distribution
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DDL Consumer Discretionary
- RLAY Health Care
- Exchange
- DDL Nasdaq
- RLAY Nasdaq
- Market Cap
- DDL 685.7M
- RLAY 578.1M
- IPO Year
- DDL 2021
- RLAY 2020
- Fundamental
- Price
- DDL $2.95
- RLAY $3.41
- Analyst Decision
- DDL
- RLAY Strong Buy
- Analyst Count
- DDL 0
- RLAY 10
- Target Price
- DDL N/A
- RLAY $19.33
- AVG Volume (30 Days)
- DDL 866.2K
- RLAY 2.1M
- Earning Date
- DDL 03-06-2025
- RLAY 05-01-2025
- Dividend Yield
- DDL N/A
- RLAY N/A
- EPS Growth
- DDL N/A
- RLAY N/A
- EPS
- DDL 0.13
- RLAY N/A
- Revenue
- DDL $3,158,412,712.00
- RLAY $10,007,000.00
- Revenue This Year
- DDL $17.17
- RLAY N/A
- Revenue Next Year
- DDL $14.00
- RLAY $544.28
- P/E Ratio
- DDL $23.28
- RLAY N/A
- Revenue Growth
- DDL 4.61
- RLAY N/A
- 52 Week Low
- DDL $1.08
- RLAY $3.02
- 52 Week High
- DDL $4.79
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- DDL 39.52
- RLAY 42.33
- Support Level
- DDL $3.04
- RLAY $3.09
- Resistance Level
- DDL $3.68
- RLAY $3.61
- Average True Range (ATR)
- DDL 0.24
- RLAY 0.34
- MACD
- DDL -0.04
- RLAY 0.03
- Stochastic Oscillator
- DDL 17.05
- RLAY 39.39
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).